Tech Company Financing Transactions
Copernicus Therapeutics Funding Round
Copernicus Therapeutics, based in Cleveland, secured $825 thousand in funding from Vivo Capital.
Transaction Overview
Company Name
Announced On
6/30/2005
Transaction Type
Venture Equity
Amount
$825,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11000 Cedar Ave. 145
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Website
Email Address
Overview
Copernicus Therapeutics, Inc. is a privately-held company developing products for human gene therapy and vaccination. Copernicus was established in 1997 based on technologies discovered at Case Western Reserve University that provide the foundation for the use of DNA as drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Moen
Chief Medical Officer
Mark Cooper
Browse more venture capital transactions:
Prev: 6/30/2005: Traverse Networks venture capital transaction
Next: 6/30/2005: Aritas Securities venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs